0000899243-18-014735.txt : 20180601
0000899243-18-014735.hdr.sgml : 20180601
20180601182956
ACCESSION NUMBER: 0000899243-18-014735
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180530
FILED AS OF DATE: 20180601
DATE AS OF CHANGE: 20180601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Francis Chris
CENTRAL INDEX KEY: 0001657709
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37627
FILM NUMBER: 18876393
MAIL ADDRESS:
STREET 1: C/O WAVE LIFE SCIENCES LTD.
STREET 2: 733 CONCORD AVE.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Wave Life Sciences Ltd.
CENTRAL INDEX KEY: 0001631574
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: U0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7 STRAITS VIEW
STREET 2: #12-00, MARINA ONE EAST TOWER
CITY: SINGAPORE
STATE: U0
ZIP: 018936
BUSINESS PHONE: 617-949-2900
MAIL ADDRESS:
STREET 1: 733 CONCORD AVENUE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
FORMER COMPANY:
FORMER CONFORMED NAME: WAVE Life Sciences Ltd.
DATE OF NAME CHANGE: 20170516
FORMER COMPANY:
FORMER CONFORMED NAME: Wave Life Sciences Ltd.
DATE OF NAME CHANGE: 20151106
FORMER COMPANY:
FORMER CONFORMED NAME: Wave Life Sciences LTD.
DATE OF NAME CHANGE: 20151106
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-30
0
0001631574
Wave Life Sciences Ltd.
WVE
0001657709
Francis Chris
C/O WAVE LIFE SCIENCES LTD.,
733 CONCORD AVE.
CAMBRIDGE
MA
02138
0
1
0
0
See Remarks
Ordinary Shares
2018-05-30
4
M
0
24496
2.48
A
46573
D
Ordinary Shares
2018-05-30
4
S
0
24496
45.50
D
22077
D
Ordinary Shares
2018-06-01
4
M
0
24496
2.48
A
46573
D
Ordinary Shares
2018-06-01
4
S
0
24496
48.00
D
22077
D
Share Option (right to buy)
2.48
2018-05-30
4
M
0
24496
0.00
D
2025-03-10
Ordinary Shares
24496
101564
D
Share Option (right to buy)
2.48
2018-06-01
4
M
0
24496
0.00
D
2025-03-10
Ordinary Shares
24496
77068
D
The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018.
The share option represented a right to purchase a total of 126,174 ordinary shares, 25% of which became exercisable on April 15, 2015, and the remaining shares vest in 36 equal monthly installments thereafter.
SVP, Corporate Development, Head of Emerging Areas
/s/ Chris Francis
2018-06-01